Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 23165505)

1.
2.

Update on pharmaceutical trials in acute spinal cord injury.

Lammertse DP.

J Spinal Cord Med. 2004;27(4):319-25. Review.

PMID:
15484662
3.

Promising pharmacological agents in the management of acute spinal cord injury.

Seidl EC.

Crit Care Nurs Q. 1999 Aug;22(2):44-50. Review.

PMID:
10646442
4.

New drugs for improving injury outcome in spinal cord injuries.

Werner PC.

West J Med. 1997 Apr;166(4):271-2. No abstract available.

5.

The Sir Ludwig Guttmann lecture 2012: the contribution of Stoke Mandeville Hospital to spinal cord injuries.

Frankel HL.

Spinal Cord. 2012 Nov;50(11):790-6. doi: 10.1038/sc.2012.109. Epub 2012 Oct 9.

PMID:
23045299
6.

Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury.

Hawryluk GW, Rowland J, Kwon BK, Fehlings MG.

Neurosurg Focus. 2008;25(5):E14. doi: 10.3171/FOC.2008.25.11.E14. Review.

PMID:
18980474
7.

Promising pharmacological agents in the management of acute spinal cord injury.

Seidl EC.

Pharm Pract Manag Q. 2000 Apr;20(1):21-7. Review.

PMID:
10947539
8.

Clinical applications of pharmacologic therapies for spinal cord injury.

Zeidman SM, Ling GS, Ducker TB, Ellenbogen RG.

J Spinal Disord. 1996 Oct;9(5):367-80. Review.

PMID:
8938604
9.

Clinical trials in spinal cord injury.

Blight AR, Tuszynski MH.

J Neurotrauma. 2006 Mar-Apr;23(3-4):586-93. Review.

PMID:
16629639
10.

Donald Munro Lecture. Spinal cord injury--past, present, and future.

Donovan WH.

J Spinal Cord Med. 2007;30(2):85-100. Review.

11.

Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury.

Tator CH, Hashimoto R, Raich A, Norvell D, Fehlings MG, Harrop JS, Guest J, Aarabi B, Grossman RG.

J Neurosurg Spine. 2012 Sep;17(1 Suppl):157-229. doi: 10.3171/2012.5.AOSPINE12116. Review.

PMID:
22985382
12.

Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury.

Geisler FH, Dorsey FC, Coleman WP.

Ann Emerg Med. 1993 Jun;22(6):1041-7. Review.

PMID:
8503523
13.

From basics to clinical: a comprehensive review on spinal cord injury.

Silva NA, Sousa N, Reis RL, Salgado AJ.

Prog Neurobiol. 2014 Mar;114:25-57. doi: 10.1016/j.pneurobio.2013.11.002. Epub 2013 Nov 20. Review.

PMID:
24269804
14.

Spinal cord injury clinical trials translational process, review of past and proposed acute trials with reference to recommended trial guidelines.

Steeves J, Blight A.

Handb Clin Neurol. 2012;109:386-98. doi: 10.1016/B978-0-444-52137-8.00024-3.

PMID:
23098726
15.

Outcome measures: evolution in clinical trials of neurological/functional recovery in spinal cord injury.

Ditunno JF.

Spinal Cord. 2010 Sep;48(9):674-84. doi: 10.1038/sc.2009.198. Epub 2010 Feb 2.

PMID:
20125111
16.

GM-1 ganglioside and motor recovery following human spinal cord injury.

Geisler FH.

J Emerg Med. 1993;11 Suppl 1:49-55.

PMID:
8445203
17.

Effectiveness and cost-effectiveness of acute hospital-based spinal cord injuries services: systematic review.

Bagnall AM, Jones L, Richardson G, Duffy S, Riemsma R.

Health Technol Assess. 2003;7(19):iii, 1-92. Review.

18.

Spinal cord injury: the promise of translational research.

Fehlings MG, Tighe A.

Neurosurg Focus. 2008;25(5):E1. doi: 10.3171/FOC.2008.25.11.E1. Review.

PMID:
18980469
19.

The historical evolution of the management of spinal cord injury.

Schiller MD, Mobbs RJ.

J Clin Neurosci. 2012 Oct;19(10):1348-53. doi: 10.1016/j.jocn.2012.03.002. Epub 2012 Aug 20.

PMID:
22917760
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk